GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Klaria Pharma Holding AB (STU:6FN) » Definitions » YoY EPS Growth

Klaria Pharma Holding AB (STU:6FN) YoY EPS Growth : -25.00% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Klaria Pharma Holding AB YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Klaria Pharma Holding AB's YoY EPS Growth for the quarter that ended in Dec. 2024 was -25.00%.

Klaria Pharma Holding AB's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was €-0.01.


Klaria Pharma Holding AB YoY EPS Growth Historical Data

The historical data trend for Klaria Pharma Holding AB's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klaria Pharma Holding AB YoY EPS Growth Chart

Klaria Pharma Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -71.88 14.55 -6.38 68.00 -3.13

Klaria Pharma Holding AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.00 -100.00 -11.11 37.50 -25.00

Klaria Pharma Holding AB YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Klaria Pharma Holding AB's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(-0.033--0.032)/ | -0.032 |
=-3.13 %

Klaria Pharma Holding AB's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 )) |
=(-0.01--0.008)/ | -0.008 |
=-25.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Klaria Pharma Holding AB YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Klaria Pharma Holding AB's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Klaria Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Virdings Alle 2, Uppsala, SWE, 754 50
Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group's operations are conducted in Sweden.

Klaria Pharma Holding AB Headlines

No Headlines